Evidence map›Paper›PMID 25888212›Full record

ArticleBMC complementary and alternative medicine2015

Anti-emetic mechanisms of Zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlates.

Ihsan Ullah, Fazal Subhan, Muhammad Ayaz, Rehmat Shah, Gowhar Ali, Ikram Ul Haq, Sami Ullah

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Thyme Oil and Thymol Counter Doxorubicin-Induced HepatotoxicityOxidative medicine and cellular longevity · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Suppression of Cisplatin-Induced Vomiting byFrontiers in pharmacology · 2018
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Ihsan UllahDepartment of Pharmacy, University of Swabi, Swabi, Pakistan. Ihsanmkd@gmail.com.
Fazal SubhanDepartment of Pharmacy, University of Peshawar, Peshawar, Pakistan. Fazal_subhan@upesh.edu.pk.
Muhammad AyazDepartment of Pharmacy, University of Malakand, Chakdara, Dir Lower, Pakistan. Ayazuop@gmail.com.
Rehmat ShahDepartment of Pharmacy, University of Peshawar, Peshawar, Pakistan. rehmatshah@upesh.edu.pk.
Gowhar AliDepartment of Pharmacy, University of Peshawar, Peshawar, Pakistan. gohar.pharmacist@gmail.com.
Ikram Ul HaqNational Institute of Health, Islamabad, Pakistan. Ikram_pharmacist@yahoo.com.
Sami UllahDepartment of Pharmacy, University of Peshawar, Peshawar, Pakistan. samiullah@upesh.edu.pk.
University of Peshawar · PKKhyber Teaching Hospital · PKNational Institute of Health · PKUniversity of Malakand · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundZingiber officinale (ZO, family Zingiberaceae) has been reported for its antiemetic activity against cancer chemotherapy induced emesis in animal models and in clinics. Current study was designed to investigate ZO for potential usefulness against cisplatin induced vomiting in pigeon and its effects on central and peripheral neurotransmitters involved in the act of vomiting.

methodsZingiber officinale acetone fraction (ZO-ActFr) was investigated for attenuation of emesis induced by cisplatin in healthy pigeons. Neurotransmitters DA, 5HT and their metabolites DOPAC, HVA and 5HIAA were analyzed using High Performance Liquid Chromatography system coupled with electrochemical detector in area postrema, brain stem and intestine. Antiemetic effect of ZO-ActFr was correlated with central and intestinal neurotransmitters levels in pigeon.

resultsCisplatin (7 mg/kg i.v.) induced emesis without lethality upto the observation period. ZO-ActFr (25, 50 & 100 mg/kg) attenuated cisplatin induced emesis ~ 44.18%, 58.13% (P < 0.05) and 27.9%, respectively; the reference drug, metoclopramide (MCP; 30 mg/kg), produced ~ 48.83% reduction (P < 0.05). ZO-ActFr reduced (P < 0.05 - 0.001) 5-hydroxytryptamine (5HT) concentration in the area postrema, brain stem and intestine at 3(rd) hour of cisplatin administration, while at the 18(th) hour ZO treatments attenuated the dopamine upsurge (P < 0.001) caused by cisplatin in the area postrema and 5HT concentration (P < 0.01 - 0.001) in the brain stem and intestine. ZO treatments alone did not altered the basal neurotransmitters and their metabolites in the brain areas and intestine.

conclusionThe behavioral study verify the antiemetic profile of ZO against cisplatin induced emesis in the pigeon, where central and peripheral neural evidences advocate the involvement of serotonergic mechanism at initial time point (3(rd) hr), while the later time point (18(th) hr) is associated with serotonergic and dopaminergic component in the mediation of its antiemetic effect.

Indexed as

PhytotherapyZingiber officinaleAnimalsAntiemeticsAntineoplastic AgentsBehavior, AnimalCisplatinColumbidaeDopamineFemaleMalePlant ExtractsSerotoninVomitingAntiemeticsAntineoplastic AgentsCisplatinDopaminePlant ExtractsSerotonin

Identifiers

PMID25888212
PMCPMC4355376
OpenAlexW2070251133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.